Tower Research Capital (TRC)’s Benitec Biopharma BNTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.21K | Buy |
+445
| New | +$5.21K | ﹤0.01% | 4215 |
|
|
2025
Q1 | – | Sell |
-1,099
| Closed | -$13.9K | – | 5223 |
|
|
2024
Q4 | $13.9K | Buy |
1,099
+869
| +378% | +$11K | ﹤0.01% | 3497 |
|
|
2024
Q3 | $2.11K | Sell |
230
-661
| -74% | -$6.08K | ﹤0.01% | 5051 |
|
|
2024
Q2 | $6.23K | Sell |
891
-854
| -49% | -$5.97K | ﹤0.01% | 4604 |
|
|
2024
Q1 | $9.16K | Sell |
1,745
-750
| -30% | -$3.94K | ﹤0.01% | 3885 |
|
|
2023
Q4 | $8.06K | Buy |
2,495
+2,299
| +1,173% | +$7.43K | ﹤0.01% | 4551 |
|
|
2023
Q3 | $592 | Sell |
196
-243
| -55% | -$734 | ﹤0.01% | 5527 |
|
|
2023
Q2 | $1.78K | Sell |
439
-6
| -1% | -$24 | ﹤0.01% | 5297 |
|
|
2023
Q1 | $2K | Hold |
445
| – | – | ﹤0.01% | 5315 |
|
|
2022
Q4 | $1K | Sell |
445
-11
| -2% | -$25 | ﹤0.01% | 5555 |
|
|
2022
Q3 | $3K | Buy |
456
+230
| +102% | +$1.51K | ﹤0.01% | 5366 |
|
|
2022
Q2 | $4K | Buy |
226
+132
| +140% | +$2.34K | ﹤0.01% | 5172 |
|
|
2022
Q1 | $4K | Buy |
+94
| New | +$4K | ﹤0.01% | 5181 |
|
|
2021
Q2 | – | Sell |
-8
| Closed | -$1K | – | 5479 |
|
|
2021
Q1 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 5146 |
|
|
2016
Q4 | – | Sell |
-4
| Closed | -$1K | – | 3831 |
|
|
2016
Q3 | $1K | Hold |
4
| – | – | ﹤0.01% | 3260 |
|
|
2016
Q2 | $1K | Sell |
4
-1
| -20% | -$250 | ﹤0.01% | 4122 |
|
|
2016
Q1 | $2K | Buy |
+5
| New | +$2K | ﹤0.01% | 3332 |
|